Resolve Therapeutics and Institut Pasteur collaborate to identify cell-free RNA triggers in autoimmunity (opens in new tab)

Resolve Therapeutics and Institut Pasteur de Montevideo today announce a collaboration to use REJOIN-seq to identify the cell-free RNA (cfRNA) molecules that drive cytokine production and inflammation in autoimmunity. Resolve Therapeutics, a next-generation biopharma company transforming the treatment of autoimmune diseases with innovative non-immunosuppressive drugs (Resolve Therapeutics) and the Institut Pasteur de Montevideo, the ...